# B. Braun Melsungen AG clinical trials: 47 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 47 trials with B. Braun Melsungen AG as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by B. Braun Melsungen AG: 47 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/b-braun-melsungen-ag

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 47
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 47, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 23, 2026 | NCT07363161 | BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary... | B. Braun Melsungen AG | Not applicable | Recruiting | Coronary Artery Disease (CAD) | 2,184 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07363161) |
| November 18, 2021 | NCT05124821 | Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed | B. Braun Melsungen AG | Observational | Completed | Central Venous Catheter | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05124821) |
| December 2, 2020 | NCT04649931 | Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease) | B. Braun Melsungen AG | Observational | Completed | SARS (Severe Acute Respiratory Syndrome), Covid19 | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04649931) |
| October 14, 2020 | NCT04586998 | Comparison Between Propofol Concentration in Exhaled Breath and Blood Plasma Using the Exhaled Drug Monitor "Edmon" | B. Braun Melsungen AG | Not applicable | Withdrawn | Elective Surgical Procedures, Anesthesia, Intravenous | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04586998) |
| September 21, 2020 | NCT04556318 | Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19) | B. Braun Melsungen AG | Observational | Completed | Covid19 | 396 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04556318) |
| July 14, 2020 | NCT04470934 | SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) | B. Braun Melsungen AG | Observational | Active not recruiting | Coronary Artery Disease, Myocardial Ischaemia | 1,302 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04470934) |
| January 18, 2019 | NCT03809715 | Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF) | B. Braun Melsungen AG | Observational | Completed | Coronary Artery Disease | 3,520 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03809715) |
| September 14, 2017 | NCT03282955 | The HOME Study (HPN With OMEGA-3) | B. Braun Melsungen AG | Phase 4 | Completed | Patients Requiring Home Parenteral Nutrition | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03282955) |
| January 9, 2017 | NCT03013803 | Acceptability Study on Nutricomp® Drink Plus Fibre in Adults | B. Braun Melsungen AG | Not applicable | Completed | Adult Patients in Need of High-energy Oral Nutritional Supplementation | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03013803) |
| September 19, 2016 | NCT02905214 | Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended) | B. Braun Melsungen AG | Observational | Completed | Coronary Artery Disease (CAD) | 4,369 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02905214) |
| September 14, 2016 | NCT02900274 | "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Extended) | B. Braun Melsungen AG | Observational | Completed | Peripheral Arterial Occlusive Disease | 353 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02900274) |
| March 22, 2016 | NCT02715466 | Gelatin in ICU and Sepsis | B. Braun Melsungen AG | Phase 4 | Terminated | Hypovolemia | 167 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02715466) |
| December 14, 2015 | NCT02629575 | Coroflex ISAR 2000 Registry | B. Braun Melsungen AG | Observational | Completed | Coronary Artery Disease (CAD) | 2,877 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02629575) |
| September 18, 2015 | NCT02554292 | Post Market Surveillance of SeQuent Please Neo With Scoring Balloon | B. Braun Melsungen AG | Observational | Completed | Coronary Artery Disease (CAD) | 481 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02554292) |
| August 24, 2015 | NCT02531230 | "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes | B. Braun Melsungen AG | Observational | Completed | Peripheral Arterial Occlusive Disease | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02531230) |
| July 13, 2015 | NCT02495285 | Gelatines in Pediatric PatientS | B. Braun Melsungen AG | Observational | Completed | Treatment of Hypovolemia and Shock | 601 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02495285) |
| June 2, 2015 | NCT02460042 | Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW) | B. Braun Melsungen AG | Observational | Completed | Peripheral Arterial Occlusive Disease | 960 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02460042) |
| May 8, 2015 | NCT02439177 | Evaluating System Accuracy and User Performance of Omnitest® Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus | B. Braun Melsungen AG | Not applicable | Terminated | Diabetes | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02439177) |
| November 13, 2014 | NCT02290067 | System Accuracy and User Performance of Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus | B. Braun Melsungen AG | Not applicable | Completed | Diabetes | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02290067) |
| August 12, 2014 | NCT02213965 | Study Comparing the Handling of Two Peripheral IV Catheter Systems | B. Braun Melsungen AG | Observational | Completed | Intravenous Access According to Instructions For Use | 2,340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02213965) |
| July 22, 2014 | NCT02197013 | Evaluation of Introcan Safety 3 Closed IV Catheter | B. Braun Melsungen AG | Observational | Completed | Patients in Need for Intravenous Access | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02197013) |
| October 28, 2013 | NCT01970605 | Silver Graft All Comers Registry | B. Braun Melsungen AG | Observational | Completed | Aneurysm, Graft Failure, Graft Infection | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01970605) |
| October 28, 2013 | NCT01970579 | Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter | B. Braun Melsungen AG | Phase 3 | Completed | Stenosis, Restenosis | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01970579) |
| March 20, 2013 | NCT01814956 | Different Lipid Emulsions in Acute Lung Injury Patients | B. Braun Melsungen AG | Phase 4 | Terminated | Parenteral Nutrition | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01814956) |
| February 1, 2012 | NCT01523665 | Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System | B. Braun Melsungen AG | Observational | Completed | Intensive Care Patients | 508 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01523665) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 1 |
| Phase 3 | 10 |
| Phase 4 | 7 |
| Not applicable | 11 |
| Observational | 18 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 40 |
| Terminated | 4 |
| Recruiting | 1 |
| Withdrawn | 1 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Critical Illness | 7 |
| Coronary Artery Disease | 6 |
| Insulin Resistance | 6 |
| Peripheral Arterial Occlusive Disease 1 | 3 |
| Hyperphagia | 3 |
| Hypovolemia | 2 |
| Diabetes Mellitus | 2 |
| COVID-19 | 2 |
| Shock | 2 |
| Constriction, Pathologic | 1 |
| Sepsis | 1 |
| Renal Insufficiency | 1 |
| Premature Birth | 1 |
| Aneurysm | 1 |
| Gastrointestinal Neoplasms | 1 |
| Severe Acute Respiratory Syndrome | 1 |
| Myocardial Ischemia | 1 |
| Pain | 1 |
| Malnutrition | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Preschools in the United States](https://specstream.ai/data/businesses/preschools/united-states)
- [Electronic parts suppliers in the United States](https://specstream.ai/data/businesses/electronic-parts-suppliers/united-states)
- [Tires manufacturers in the United States](https://specstream.ai/data/businesses/tires-manufacturers/united-states)
- [Indian restaurants in the United States](https://specstream.ai/data/businesses/indian-restaurants/united-states)
- [B2B medical support companies in the United States](https://specstream.ai/data/businesses/b2b-medical-support-companies/united-states)
- [Outpatient care facilities in the United States](https://specstream.ai/data/businesses/outpatient-care-facilities/united-states)
